Abstract
Current vaccines for Covid-19 have failed to prevent the disease from spreading and have allowed more transmissible and virulent variants to form through mutations and recombinations as they replicate during the massive spread of the virions. Here I suggest using a “systems therapeutic” vaccine and dosing strategy to induce “physiological renormalization” to induce mimicry in the innate and adaptive immune systems in the respiratory tracts and sera, similar to that when the body encounters the natural infectious agent.
All Keywords
【초록키워드】 Vaccine, Mutation, variant, Spread, sera, Recombination, respiratory tract, infectious agent, adaptive immune system, virions, virulent, respiratory tracts, Prevent, mimicry, current, the disease, replicate, induce, 【제목키워드】 Vaccine development, therapeutic, physiological, approach, example,
【초록키워드】 Vaccine, Mutation, variant, Spread, sera, Recombination, respiratory tract, infectious agent, adaptive immune system, virions, virulent, respiratory tracts, Prevent, mimicry, current, the disease, replicate, induce, 【제목키워드】 Vaccine development, therapeutic, physiological, approach, example,
{{{ 추상적인 }}}
현재 코비드-19 백신은 질병의 확산을 막는 데 실패했으며, 바이러스가 대규모로 확산되는 동안 복제할 때 돌연변이와 재조합을 통해 더 많은 전염성 및 독성 변이체가 형성되도록 허용했습니다. 여기서 나는 "생리학적 재정규화"를 유도하는 "시스템 치료" 백신과 투여 전략을 사용하여 신체가 자연 감염원을 만났을 때와 유사한 호흡기 및 혈청의 선천 및 후천 면역계에서 모방을 유도할 것을 제안합니다.